Skip to main content
Advanced Technical IVT

neoantigen

Pronunciation: NEE-oh-AN-ti-jen

A new protein fragment created by tumor mutations that can be recognized by the immune system.

Full Definition

Neoantigens are novel protein sequences generated by tumor-specific mutations that are not present in normal cells, making them potential targets for immune recognition. These mutant proteins are processed and presented on the tumor cell surface by MHC molecules, where they can be recognized as foreign by T cells. The presence and quality of neoantigens influence tumor immunogenicity and response to immunotherapy, with tumors harboring more neoantigens generally showing better responses to checkpoint inhibitors and being candidates for personalized cancer vaccines.

Usage

Usage note: Write as one word; distinguish from broader category of tumor antigens.

In Context

  • "The patient's tumor harbored 47 predicted neoantigens suitable for personalized vaccine development." — Genomic analysis report
  • "Neoantigen load correlates with response to PD-1 blockade across multiple cancer types." — Biomarker research paper

Also known as

tumor neoantigen mutation-associated antigen

Contrasted with

self-antigen tumor-associated antigen

Don't confuse with

tumor antigen viral antigen cancer testis antigen

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON